Cannabinoids/Marijuana Test Volume and Sales Forecasts to 2021: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations

Cannabinoids/Marijuana Test Volume and Sales Forecasts to 2021: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations

  • June 2017 •
  • Report ID: 4950053 •
  • Format: PDF

This new report from VPGMarketResearch.com provides analysis of Cannabinoids/Marijuana testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

Geographic Coverage

France, Germany, Italy, Japan, Spain, UK, USA

Market Segmentation

Centralized Testing

- Hospitals
- Commercial/Private Laboratories

POC/Decentralized Testing

- Physician Offices/Group Practices
- Emergency Departments
- Ambulatory Care Centers

List of Tables

France: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
UK: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
USA: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment